Bayer Change in Inventories 2010-2024 | BAYRY
Bayer annual/quarterly change in inventories history and growth rate from 2010 to 2024. Change in inventories can be defined as the increase or decrease in a company's inventories for the period.
- Bayer change in inventories for the quarter ending December 31, 2024 was $0.564B, a 221.14% decline year-over-year.
- Bayer change in inventories for the twelve months ending December 31, 2024 was $3.228B, a 420.47% decline year-over-year.
- Bayer annual change in inventories for 2024 was $0.564B, a 221.14% decline from 2023.
- Bayer annual change in inventories for 2023 was $-0.465B, a 79.64% decline from 2022.
- Bayer annual change in inventories for 2022 was $-2.286B, a 1017.04% increase from 2021.
Bayer Annual Change in Inventories
(Millions of US $) |
| 2024 |
$564 |
| 2023 |
$-465 |
| 2022 |
$-2,286 |
| 2021 |
$-205 |
| 2020 |
$-1,028 |
| 2019 |
$-115 |
| 2018 |
$726 |
| 2017 |
$-331 |
| 2016 |
$-3 |
| 2015 |
$-208 |
| 2014 |
$-985 |
| 2013 |
$-808 |
| 2012 |
$-867 |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$27.783B |
$50.438B |
|
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
|
